DNA X, Inc. (SONM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for DNA X, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.11x | -7.98x | -6303.00x | -15.69x | -4.07x | -20.12x |
| P/B Ratio | -0.34x | -47.08x | 25.36x | 11.03x | 8.43x | 21.20x |
| P/S Ratio | 0.00x | 4.60x | 6.06x | 3.16x | 2.88x | 9.41x |
| Profitability | ||||||
| Gross Margin | 0.0% | 17.0% | 20.6% | 16.6% | 11.8% | 23.8% |
| Operating Margin | 0.0% | -57.7% | 0.5% | -20.5% | -69.6% | -45.7% |
| Net Margin | 0.0% | -57.7% | -0.1% | -20.2% | -70.8% | -46.8% |
| EBITDA Margin | 0.0% | -51.2% | 2.7% | -16.4% | -66.6% | -42.1% |
| Liquidity | ||||||
| Current Ratio | 0.60x | 0.74x | 1.36x | 1.36x | 1.70x | 2.23x |
| Quick Ratio | 0.60x | 0.49x | 1.16x | 1.24x | 1.44x | 1.67x |
| Leverage | ||||||
| Debt/Equity | -0.78x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x |
YoY = year-over-year change. Source: FMP..